Ollin Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$330M
- Investors
-
9
Ollin General Information
Description
Developer of ophthalmic therapeutics designed to treat vision-threatening eye diseases and preserve patient vision. The company offers bispecific antibody drug candidates, translational research capabilities, and insights-driven development programs, enabling patients with retinal and ophthalmic disorders to access therapies aimed at improving disease control and treatment outcomes.
Contact Information
Website
www.ollin.bioCorporate Office
- Austin, TX
- United States
Corporate Office
- Austin, TX
- United States
Ollin Timeline
Ollin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 24-Jun-2026 | $330M | Completed | Clinical Trials - Phase 3 | ||
| 1. Early Stage VC (Series A) | 17-Sep-2025 | Completed | Clinical Trials - Phase 3 |
Ollin Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Ollin Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Ollin Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ollin Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Andreessen Horowitz | Venture Capital | Minority | ||
| Blackstone | PE/Buyout | Minority | ||
| Commodore Capital | Venture Capital | Minority | ||
| CPP Investments | Asset Manager | Minority | ||
| RA Capital Management | Asset Manager | Minority |
Ollin FAQs
-
When was Ollin founded?
Ollin was founded in 2022.
-
Where is Ollin headquartered?
Ollin is headquartered in Austin, TX.
-
What is the size of Ollin?
Ollin has 21 total employees.
-
What industry is Ollin in?
Ollin’s primary industry is Drug Discovery.
-
Is Ollin a private or public company?
Ollin is a Private company.
-
What is the current valuation of Ollin?
The current valuation of Ollin is .
-
What is Ollin’s current revenue?
The current revenue for Ollin is .
-
How much funding has Ollin raised over time?
Ollin has raised $430M.
-
Who are Ollin’s investors?
Andreessen Horowitz, Blackstone, Commodore Capital, CPP Investments, and RA Capital Management are 5 of 9 investors who have invested in Ollin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
